- About Us
- Executive Committee
- Company Papers
- Your Privacy
- Corporate Supporters
- Professional Development
- Respiratory Leadership Programme
- Peer Support Networks
- Fit to Care
- PCRS Scientific Mentorship Programme
- Primary Care Respiratory Academy
- PCRS Lifelong Learning
- Policy & Campaigns
- Become a Member
Confirmed Conference Exhibitors
We look forward to welcoming our exhibitors to the conference. Exhibitors have had no input into the agenda of the conference, with the exception of the satellite symposium sessions, for which the sponsoring companies are fully responsible.
To enquire about exhibiting opportunities, please contact Kim for more information.
Action for Pulmonary Fibrosis (APF) is a growing community of patients, families, researchers and healthcare professionals striving to find a cure for pulmonary fibrosis so everyone affected by the disease has a better future. We provide personalised support to patients and families - and raise awareness of pulmonary fibrosis through campaigning, fundraising and education. We are also committed to funding research to improve the quality of life for people living with pulmonary fibrosis today and tomorrow.
We are conducting one of the largest ever randomised trials in childhood asthma, and would be delighted if you would like your practice to join us!
The trial is funded by NIHR, and conducted with routinely collected Primary Care data. We have tried to make it as easy as possible for practices to participate.
Our trial is comparing two regimes for inhaled corticosteroids in children with mild asthma:
"Daily" versus "Symptom-driven"
Here is a very short video of Professor Chris Griffiths explaining the study.
The trial is run using the Clinical Practice Research Datalink - more information here: https://www.cprd.com/
It is easy for your practice to join CPRD and enrol in the study. We hope you will be able to help us conduct this important study.
The Association for Respiratory Technology and Physiology (ARTP) are the professional guardians of physiological measurement and interpretation within the field of respiratory medicine for the United Kingdom. Drawing on a wealth of knowledge, skills and experience, we are a collection of healthcare scientists who bring inspiration and quality into respiratory healthcare.
The Association of Chartered Physiotherapists in Respiratory Care is a National Body which promotes health and best practice in Respiratory Physiotherapy for the benefit of all.
The ACPRC was originally established in 1980, and with over 1,400 members is one of the largest professional networks of physiotherapists in the UK .
Each year, the ACPRC publish the only journal dedicated to Respiratory Physiotherapy, a Respiratory Review and a monthly e-Newsletter with all of the latest updates in Respiratory Care. The committee also deliver a wide range of short courses, a bi-annual conference and support members with a wide range of general enquiries.
Since 2016, the four core pillars of the ACPRC have been:
Sharing Knowledge and Skills
Research and Best Practice
Leadership and Innovation
The ACPRC is run by an elected committee of members who support the organisation on a voluntary basis. The committee itself is made up of a wide range of specialist physiotherapists, many of whom are leading figures in their area of expertise.
The Association of Respiratory Nurse Specialists (ARNS) is a membership association and nursing forum to champion the specialty respiratory nursing community, promote excellence in practice, and influence respiratory health policy. ARNS also works to influence the direction of respiratory nursing care.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
For more information, please visit www.astrazeneca.com and follow us on Twitter @AstraZeneca.
About Boehringer Ingelheim
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The company concentrates on developing innovative therapies that can improve patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas: human pharmaceuticals, animal health and biopharmaceuticals.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.
The British Thoracic Society (BTS) is the largest, most authoritative and most inclusive respiratory professional Society in the UK. We have over 4,000 members across the entire respiratory workforce and healthcare settings, including doctors, nurses, respiratory physiotherapists, physiologists, scientists and other professionals with a respiratory interest. Around 11% of our membership is engaged in our activities during the year.
We work to achieve better lung health for all, and we partner with like-minded institutions to achieve this goal; in particular we collaborate closely with the Primary Care Respiratory Society to support seamless integrated respiratory care across primary and secondary care.
We raise awareness of the impact of lung disease and champion the respiratory workforce, influence healthcare policy, while developing and promoting evidence-based standards of care. Our vast quality improvement programme includes globally recognised clinical Guidelines, Quality Standards and Clinical Statements, respected national audits, and Quality Improvement toolkits. We run a comprehensive programme of short courses and an annual Summer Meeting which seeks to provide clinical updates and shared leaning. Our Winter Meeting is one of the largest single Society scientific conferences in Europe, with nearly 2,500 delegates each year.
Chiesi Limited is headquartered in Manchester and employs over 400 people. Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. To achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, Chiesi researches, develops and markets drugs in its three therapeutic areas: AIR (respiration, from new-born to adult populations), RARE (rare and ultra-rare diseases) and CARE (special care and consumer-facing self-care). Chiesi, since 2019, is the world’s largest B Corp certified pharmaceutical group. Further information: www.chiesi.uk.com
Education for Health is leading UK based charity with over three decades of experience delivering education, training and support services to healthcare professionals. We equip healthcare professionals with the knowledge and know-how to provide high quality care for those with long term conditions and improve health outcomes.
Our Learning Academy provides a range of interactive online workshops, resource toolkits and eLearning. These are ideal for those who are looking for high quality bite sized learning.
For those wanting accredited, academic-based education, we also offer a range of undergraduate degree short courses along with two full Masters programmes and a range of Postgraduate degree level modules. These are all accredited by the University of Hertfordshire.
Find out more about Education for Health and our education, training and support services via our website. Or get in touch directly via email at email@example.com.
Glenmark Pharmaceuticals Europe Limited
Founded more than 40 years ago, Glenmark Pharmaceuticals is a global pharmaceutical company with a track record of achievement, improving patients’ lives with access to affordable medicines.
We opened our UK operations in 2004 and have emerged as a key generics organization in the UK. Today we have a diverse business. As a global leader in generics, we are leveraging our industry expertise and success to fuel extensive research and develop innovative, branded products that will have a major impact on how people live. We are also active in supplying medicines to NHS Hospitals.
The International Primary Care Respiratory Group (IPCRG) is a clinically-led charitable company that works locally in primary care and collaborates globally to improve respiratory health. Our vision is that, through universal access to the right care, everyone can breathe and feel well.
We are an alliance of 37 national primary care respiratory organisations, reaching over 150,000 GPs and other primary care professionals around the world. We are also a community of practice, collaborating globally on respiratory research and innovation, and exchanging knowledge about best practice and impact.
We advise the World Health Organization and WONCA, extend academic learning into communities, develop global collaborative networks, and lead in the promotion of a culture of critical inquiry and public reasoning about the best ways to deliver effective respiratory care.
We’re a privately owned UK company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients.
We believe in excellence and delivering on our promises to the NHS, patients, our business partners and each other.
We strive to offer new medicines and initiatives that meet genuine needs, make a positive difference to patients’ lives and support the NHS in delivering effective, high-quality, sustainable healthcare.
Napp Pharmaceuticals Limited is a member of the Mundipharma network of independent associated companies
Nutricia pioneers nutritional solutions that help people live longer, more joyful and healthier lives.
Building on more than a century of nutritional research and innovation, Nutricia continues to transform lives through the power of nutrition.
Nutricia’s science-based products and services support healthy growth and development during the first 1000 days. Nutricia also helps to address some of the world’s biggest health challenges including conditions in early life such as pre-term birth, faltering growth, food allergy and rare metabolic diseases, as well as age-related conditions and chronic disease, such as frailty, cancer, stroke and early Alzheimer’s disease.
We make asthma monitoring easier for you and for your patients
Refer the patient to us and we send you a detailed asthma control report with PEF, Symptoms, Reliever inhaler use and ACT score.
We set the patient up with a smartphone connected peak flow meter and a self-management app that records everything digitally.
You get the report and chart via Docman and can save it with patient records.
Contact us for a free trial with 5 patients.
We are delighted to be supporting the Primary Care Respiratory Society Annual Conference to help promote the role that digital technology can take in improving the lives of patients with respiratory diseases.
We strive to promote best practice in respiratory care through our work in remote monitoring for COPD patients and Pulmonary Rehabilitation services, and our initiative with the European Space Agency on providing vulnerable patients with access to satellite-based air quality information.
CliniTouch Vie is our proven virtual clinical solution which provides monitoring, enables chronic disease management and delivers targeted education to patients, within a mobile device at home.
How it helps:
• Vital signs monitoring - uses any Bluetooth device for accurate clinical measurements.
• Health question sets - tailored to each patient's medical conditions.
• Patient education - empowers patients in self-care and wellbeing.
• Risk calculation - sophisticated algorithms assess the health risks for each patient.
• Messaging - sends messages to patients and ask them questions.
• Video calls - simple video consultations
• Prioritised caseloads - patient lists are displayed with red, amber or green status.
• Health trends - monitor how a patient's health changes over time.
To find out more, visit www.spirit-digital.co.uk or email us at firstname.lastname@example.org
The Primary Care Respiratory Society (PCRS) exists to support respiratory care practitioners in a primary or community care setting. We are a multidisciplinary UK-wide professional society, focused on developing a holistic, high value patient centred and integrated approach to caring for people with respiratory conditions. We bring together professionals from across boundaries, offering them a welcoming, supportive and non-hierarchical community.
Proud supporters of the PCRS
We delighted to showcase our new range of Healthcare solutions including ATS/ERS 2019 spirometry update compliant spirometers, remote monitoring, FeNO, and ECG.
Our high quality respiratory diagnostic devices and services allow you to have a positive impact on the diagnosis, treatment, and management of respiratory diseases.
We are excited to showcase fast, easy, and accurate spirometry with the launch of the next generation Pneumotrac PC-based spirometer combined with Spirotrac® 6 software and the Alpha desktop spirometer with a fast, integrated printer and BT12 ECG.
Both devices are compliant with the 2019 ATS/ERS spirometry update, ensuring your service meets the latest international guidelines on accuracy and reporting. Their brand-new intuitive interfaces automatically grade tests and provide quality control feedback for easy and rapid testing.
Pneumotrac, Alpha and BT12 ECG all come with FREE 5 YEAR WARRANTY and FREE ONLINE DEVICE TRAINING, and FREE CONNECT software for HL7 interfacing.
Our Eco BVF™ (Bacterial Viral Filter) range combines independently validated 99.999% bacterial and viral cross-contamination efficiency for medical personnel, patients, and equipment, with a reduced environmental impact because less plastic used in manufacturing.
Visit www.vitalograph.co.uk or call 01280 827110.